(VIANEWS) – SALMAR (SALM.OL), ALTRI SGPS (ALTR.LS), EQUASENS (EQS.PA) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. SALMAR (SALM.OL)
45.8% sales growth and 18.21% return on equity
SalMar ASA, an aquaculture company, produces and sells farmed salmon in Asia, the United States, Canada, Norway, rest of Europe, and internationally. It is involved in the broodfish, lumpfish, and smolt production activities; and marine-phase farming, harvesting, packaging, processing, and selling farmed salmon. The company sells its products to importers/exporters, processing companies, and retail chains through in-house sales force and/or through partners. SalMar ASA was founded in 1991 and is headquartered in Kverva, Norway.
Earnings Per Share
As for profitability, SALMAR has a trailing twelve months EPS of kr17.49.
PE Ratio
SALMAR has a trailing twelve months price to earnings ratio of 25.32. Meaning, the purchaser of the share is investing kr25.32 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.21%.
Moving Average
SALMAR’s worth is above its 50-day moving average of kr429.84 and under its 200-day moving average of kr484.27.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Jun 9, 2022, the estimated forward annual dividend rate is 20 and the estimated forward annual dividend yield is 4.76%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
SALMAR’s EBITDA is 43.28.
Sales Growth
SALMAR’s sales growth is 11.5% for the current quarter and 45.8% for the next.
More news about SALMAR.
2. ALTRI SGPS (ALTR.LS)
16% sales growth and 24.22% return on equity
Altri, SGPS, S.A. produces and sells bleached eucalyptus pulp in Portugal and internationally. It offers bleached eucalyptus kraft pulp for use in a range of papers, such as tissues, and printing and writing papers; and dissolving pulp for use in textile production. The company is also involved timber commercialization; forest management; the production of energy from forest resources, such as industrial cogeneration from black liquor and biomass; real estate activities; and production of plants in nurseries, as well as the provision of services related with forests and landscapes. The company was incorporated in 2005 and is headquartered in Porto, Portugal.
Earnings Per Share
As for profitability, ALTRI SGPS has a trailing twelve months EPS of €0.17.
PE Ratio
ALTRI SGPS has a trailing twelve months price to earnings ratio of 27.82. Meaning, the purchaser of the share is investing €27.82 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 24.22%.
Moving Average
ALTRI SGPS’s worth is under its 50-day moving average of €4.82 and way under its 200-day moving average of €5.48.
More news about ALTRI SGPS.
3. EQUASENS (EQS.PA)
11.3% sales growth and 28.59% return on equity
Equasens Société anonyme provides various IT solutions for the healthcare sector in Europe. It offers LGPI global services and OffiCentral solutions for managing pharmacies and their networks; OffiMSS, OffiSecure, OffiProtect, OffiPass, OffiSeen, OffiCash, Offizzy, and OffiLocker solutions for pharmacists' business processes; and solutions for energizing the customer relationship with pharmacists comprising OffiTag, OffiTouch, OffiMédia, OffiConnect, automation systems, and customer loyalty programs. The company also provides My Pilot, an analytics and management tool; OffiLearning, an e-learning tool; and solutions for patient support and advice, such as compliance monitoring software, Multimeds, Automeds, and OffiTéléconsult, as well as pharmaceutical record and shared medical record services. In addition, it offers a ULTIMATE, a system combining optimized pharmacy management and improved patient support; FARMACLICK, a protocol for communications between pharmacies and wholesalers-distributors; DIFARM, a solution for wholesalers-distributors; PHARE, a retail management tool; SOPHIA, a pharmacy management application; OffiMédia POS display; eNephro to enhance the care of chronic renal failure patients; and TPE Pilot, a web-based application that simplifies the management and sharing of patient education programs. Further, the company provides NOVIACARE; CARELIB Domicile; CARELIB EHPAD; KAPELSE solutions; TITAN solutions; ANTHADINE software and MOBISOINS mobile tool; MICROSOINS, an in-home nursing care solution; and LOGICLIC. Additionally, it offers AXIGATE solutions to manage the entire patient care pathway; CHORUS platform; medical telesecretarial services for healthcare professionals; and equipment lease financing solutions. The company was incorporated in 1996 and is based in Villers-les-Nancy, France. Equasens Société anonyme is a subsidiary of Marque Verte Sante.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 28.59%.
More news about EQUASENS.
4. SPBK1 RINGERIKE (RING.OL)
11.1% sales growth and 9.9% return on equity
SpareBank 1 Ringerike Hadeland provides various banking products and services to private and corporate customers in Norway. The company offers saving, current, deposit, and currency accounts; vehicle, house and travel, and animal insurance products, as well as life, child, disability, critical illness, accident, health, and business and personal insurance products; mobile and online banking services; and debit and credit cards. It also provides mortgages; car, boat, and other vehicles; consumer and other loans; and bank guarantees, corporate and construction loans, liquidity loans with a government guarantee, and operating credit for agriculture, as well as factoring, leasing, and overdraft services. In addition, the company offers services for buying and selling property; accounting services; pension products; and savings and investment products. The company was founded in 1833 and is based in Hønefoss, Norway.
Earnings Per Share
As for profitability, SPBK1 RINGERIKE has a trailing twelve months EPS of kr22.77.
PE Ratio
SPBK1 RINGERIKE has a trailing twelve months price to earnings ratio of 14.23. Meaning, the purchaser of the share is investing kr14.23 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.9%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 32.2% and 37.6%, respectively.
More news about SPBK1 RINGERIKE.
5. SPBK 1 NORDMØRE (SNOR.OL)
7.1% sales growth and 9.57% return on equity
SpareBank 1 Nordmøre provides various banking services in Norway. The company offers savings and deposit accounts; car, motorcycle, boat, and construction loans; and mortgages. It also provides business insurance products, which include liability, auto, mortgage, operating loss, asset, commercial, and project insurance products; personal insurance products, such as life, travel, and accidental insurance products; pension products; bank cards; payment and debt collection services; and mobile and online banking services. In addition, the company offers bank guarantees, trade credit products, and operating credit products for agriculture, as well as factoring, leasing, and repayment products and services. The company was founded in 1835 and is based in Kristiansund, Norway. SpareBank 1 Nordmøre is a subsidiary of SpareBank 1 Gruppen AS.
Earnings Per Share
As for profitability, SPBK 1 NORDMØRE has a trailing twelve months EPS of kr9.31.
PE Ratio
SPBK 1 NORDMØRE has a trailing twelve months price to earnings ratio of 13.53. Meaning, the purchaser of the share is investing kr13.53 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.57%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 52.3%, now sitting on 771M for the twelve trailing months.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 15.2% and 87.6%, respectively.
Sales Growth
SPBK 1 NORDMØRE’s sales growth is 38.5% for the ongoing quarter and 7.1% for the next.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Apr 6, 2022, the estimated forward annual dividend rate is 5 and the estimated forward annual dividend yield is 3.82%.
More news about SPBK 1 NORDMØRE.
